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Itymer, W. C., T. Salada, L. Avery, and R. E. Grinde-
land. Experimental modification of rat pituitary prolactin
cell function during and after spaceflight. J. Appl. Physiol.
80(3): 971-980, 1996.--This study was done to evaluate the
effects of microgravity on prolactin (PRL) cells of the male rat
pituitary gland. We used the identical passive closed-vial cell
culture system that was described for the culture of growth
hormone cells (W. C. Hymer, R. E. Grindeland, T. Salada, P.
Nye, E. Grossman, and P. Lane. J. Appl. Physiol. 80: 955-970,
1996). After an 8-day spaceflight, all flight media (containing
released PRL), as well as extracts (containing intracellular
PRL), contained significantly lower amounts ofimmunoreac-
tive PRL than their corresponding ground control samples.
On the other hand, these same samples, when assessed for
their biological activities by two different in vitro lymphocyte
assays, yielded disparate results that may reflect posttransla-
tional modifications to the hormone molecule. Other data
showed that 1) the apparent molecular weights of released
PRL molecules were not altered by microgravity, but 2) the
region from which the PRL cells came (dorsal or ventral)
made a significant difference in the amount and activity of
PRL released from the flight cells. Because there is much
current interest in the role that PRL may play in the
regulation of the immune system and because changes in
both cellular and humoral immunity accompany spaceflight,
this study could help define future microgravity research in
this area.
microgravity; cell culture
PROLACTIN (PRL), a pituitary hormone that bears a
structural similarity to growth hormone (GH), is well
known for its diversity of physiological actions (17).
Although originally thought to function exclusively as a
reproductive hormone, there is now convincing evi-
dence for its additional role in the modulation of the
mammalian immune system (2). Like GH, numerous
PRL variants exist within the pituitary as a result of
posttranslational modifications (20); when released from
their cells of origin into the circulation, the biological
activities of these variants may escape detection by
conventional immunoassays (10). Fortunately, two sen-
sitive in vitro bioassays for PRL are now available to
test for biological activities of secreted PRL. One of
these, the NB-2 cell bioassay, is based on the ability of
the hormone to increase cell division in a line of
T-lymphoma cells (22). The other, the interleukin-2
receptor-mitogen assay, uses fresh splenocytes from the
ovariectomized female rat to test the ability of the
hormone to either cause induction of interleukin-2 cell
surface receptors or division in these primary cells
(14, 24).
The morphology of the PRL cell in the pituitary gland
of the male rat after spaceflight was recently character-
ized by Thapar et al. (23). These authors reported that
there were neither qualitative nor quantitative morpho-
logical differences in this cell population between con-
trol and spaceflown animals. We also reported that PRL
cells of spaceflown rats had similar morphologies to
their ground-based counterparts (7). However, we also
obtained preliminary evidence that PRL cell function
might be affected by spaceflight.
The design of the 1992 pituitary cell culture experi-
ment in microgravity allowed us to further investigate
PRL cell structure and function under in vitro condi-
tions in addition to the study of the structure and
function of GH cells that is described in the companion
report (8). This report documents that changes in
intracellular and released PRL occur in cells during
and after spaceflight.
MATERIALS AND METHODS
Details relating to 1 ) experimental design, 2) cell culture
methods, 3) cell morphology methods (5), 4) high-perfor-
mance liquid chromatography (HPLC) methods, and 5) data
presentation are described in the companion report (8).
Hormone Assays
The PRL enzyme immunoassay was done exactly as de-
scribed previously (19) with polyclonal antiserum (cross-
reactivity to GH is <0.3% at a dilution of 1:40,000). Each
sample was analyzed in duplicate at two dilutions, and the
results are expressed relative to a rat PRL standard (B-7)
kindly provided by the National Institute of Diabetes and
Digestive and Kidney Diseases (Bethesda, MD) and the
National Hormone and Pituitary Program (University of
Maryland School of Medicine, Baltimore, MD).
PRL bioassays were either 1) the NB-2 lymphoma cell
division assay originally described by Tanaka et al. (22) or 2)
the mitogen assay described by ViseUi et al. (24).
Experimental constraints within this spaceflight investiga-
tion resulted in low n sizes. Accordingly, multiple a-level-
corrected independent t-tests were used to analyze these
data. This, in turn, permitted the use of an inferential
technique to highlight differences as well as strong trends.
Significance was maintained at P -< 0.05.
RESULTS
PRL Cell Morphology
The viability of all cells before and after flight was
>90%. The percentages of PRL cells in the samples at
the time of seeding, based on flow cytometry, were 1)
30% for mixed cells, 2) 38% for band I cells, and 3) 21%
for band 2 cells. After flight, these percentages, based
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Fig. 1. Flowcytometrichistogramsofpitu-
itary cells contained in mixed (A), band 1
(B), and band 2 (C) samples before seeding
into glass vials. Log peak green fluores-
cence (LPGFL) staining is specific for pro-
tactin (PRL) cells and delineates stained
[identified as cells falling to right of verti-
cal gate (vertical line)] from unstained cells
that include other hormone-producing cell
types gated from debris on basis of propidium
iodide nuclear stain. LPGFL is on a log scale,
whereas forward-angle light scatter (FALS),
a measure of cell size, is linear. Each pattern
represents a count of 30,000 cells.
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on manual counts, were 1) 23 _+ 1.5 (flight) and 21 ±
4.8% (ground) for mixed cells, 2) 19 _+ 1.5 (flight) and
24 _+ 2% (ground) for band 1 cells, and 3) 15 ± 1.4
(flight) and 13 _ 2.7% (ground) for band 2 cells.
Because cell samples were limiting, flow cytometry of
PRL cells after flight could not be done. Flow cytometric
histograms of PRL cells before flight indicated that
they were fairly uniform in size and staining intensity
(Fig. 1); this result is consistent with earlier studies (6).
Extracellular and Intracellular PRL
During and After Flight
Immunoreactive PRL (iPRL) +_hydrocortisone (HC).
Relative to ground control samples, all flight media and
intracellular extracts contained significantly less iPRL;
in every case, this flight difference disappeared in the
postflight culture period (Fig. 2). The addition of HC to
the culture medium accentuated these general pat-
Fig. 2. Release (extracelluar) and content (intra-
cellular) ofimmunoreactive PRL (Prl) from mixed,
band 1, and band 2 cells without hydrocortisone
during and after microgravity. Data are means _
SE expressed relative to number of PRL cells
seeded into vials; n = 3 vials. Error bars not
shown fit within symbol. **P < 0.01. ***P <
0.001.
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Fig. 3. Release and content of immunoreactive
PRL from mixed, band 1, and band 2 cells main-
tained in hydrocortisone-containing medium dur-
ing and after microgravity. Data are means _+SE
expressed relative to number of PRL cells seeded
into vials; n = 3 vials. Error bars not shown fit
within symbol. *P < 0.05. ***P < 0.001•
terns so that the flight differences often continued into
the postflight period (Fig. 3).
Bioactive PRL +_ HC: NB-2 cell bioassay (NB-2 PRL)
and mitogen bioassay (m-PRL). Release of NB-2 PRL
from cells in microgravity relative to ground control
samples was variable and depended on both the cell
sample and the presence of HC in the medium. HC
significantly suppressed hormone release from the
mixed and band I cells, whereas the output from band
2 cells in low gravity was significantly elevated in
HC-free medium (cf. Figs. 4 and 5). Release of NB-2
PRL during the postflight period was usually less from
the flight cells, independent of HC. A consistent reduc-
tion in the intracellular concentration of NB-2 PRL of
HC-free cells indicated that the flight cells did not
recover their intracellular contents during the 6-day
postflight period; however, if HC was present in the
culture medium, a full recovery was observed.
When these same culture media were evaluated by
the m-PRL assay, hormone release patterns were again
different. The most significant responses were those in
the postflight culture period in which flight cells often
released significantly more m-PRL than did the corre-
sponding ground control samples. However, in the
presence of HC these changes disappeared (cf. Figs. 6
and 7).
HPLC analysis of released PRL. A majority of the
iPRL molecules contained in 8-day culture media from
flight and ground cells had apparent molecular weights
ranging from 10,000 to 59,000, with a predominant
hormone peak at 29,000 (Fig. 8). There was signifi-
cantly less 10,000-59,000 iPRL contained in flight
sample media from three of the six cell groups analyzed
(Table 1). The addition of HC caused changes in the
HPLC distribution profiles ofiPRL released from mixed
and band 1 cells. In the case of mixed cells, HC
stimulated the release of high-molecular-weight iPRL
from the flight cells threefold, whereas it was reduced
by -60% in the absence of the steroid (P < 0.051). In
the case of band 2 cells, the addition of HC reduced the
release of 10,000-59,000 iPRL from ground cells to
levels comparable with those from flight cells. The
reason(s) for these changes is unknown.
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Extracellular Intracellular
Fig. 4. Release and content of bioactive (NB-2
assay) PRL from mixed, band 1, and band 2 cells
without hydrocortisone during and al_er micro-
gravity. Data are means -+ SE expressed relative
to number of PRL cells seeded into vials; n = 3
vials. Error bars not shown fit within symbol.
*P < 0.05.
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The total amount of iPRL recovered after HPLC of
flight media was always less than that from the corre-
sponding ground control groups. This result is entirely
consistent with the finding that there were lower
amounts of iPRL measured in the flight media before
fractionation. Generally, the total amount of PRL recov-
ered after HPLC of the flight and ground culture media
agreed within 10% of what was measured in the sample
before chromatography.
Substrate. Three vials containing mixed cells pre-
treated with Matrigel (a commercially available mix-
ture of basement membrane macromolecules) were also
exposed to low gravity. This treatment affected PRL
release differently depending on the assay used. Re-
lease of iPRL from flight cells was 171 +_ 10 ng/1,000
PRL cells, whereas that from ground control cells was
255 _+ 6 ng/1,000 PRL cells (P < 0.01). Because a result
of similar magnitude was found in iPRL released from
cells attached to a non-Matrigel-coated surface (Fig. 2),
we conclude that Matrigel had no additional effect on
iPRL release in flight. Release ofNB-2 PRL from mixed
cells cultured on Matrigel was markedly different
between flight and ground cells (622 _+ 222 and 84 _+ 8
ng/1,000 PRL cells, respectively; P < 0.05). Comparison
of these latter values with the release of NB-2 PRL on
non-Matrigel-coated surfaces (Fig. 4) shows that this
matrix material apparently had little effect on cell
behavior in microgravity but severely inhibited release
of NB-2 PRL at normal gravity. The reason(s) for this
interesting result is unknown; we speculate that it may
be related to the state of phosphorylation of PRL (see
DISCUSSION). The release of m-PRL from cells on the
Matrigel-coated surface was not different between flight
and ground cells (250 _+40 and 288 +_ 53 ng/1,000 PRL
cells, respectively). However, the total m-PRL output
was two times greater than that on the non-Matrigel
surface.
Cell location. Flight consistently affected the release
of PRL from cells residing in the dorsal vs. ventral
regions of the gland. The direction and magnitude of
the effect depended on the assay used. For example,
iPRL release in microgravity was lower from both
dorsal and ventral PRL cells by about the same extent
(dorsal: 211 _ 19 and 371 _+24 ng iPRL/1,000 PRL cells
for flight and ground samples, respectively, P < 0.01;
ventral: 98 _+ 2 and 162 _+ 10 ng iPRL/1,000 PRL cells
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Fig. 5. Release and content of bioactive (NB-2
assay) PRL from mixed, band 1, and band 2 cells
maintained in hydrocortisone-containing me-
dium during and after microgravity. Data are
means +- SE expressed relative to number of PRL
cells seeded into vials; n = 3 vials. Error bars not
shown fit within symbol. *P < 0.05.
for flight and ground samples, respectively, P < 0.01).
By the NB-2 assay, release from the dorsal cells was
significantly higher, whereas that from the ventral cells
was not affected by microgravity (dorsal: 420 _+ 51 and
293 _+ 44 ng NB-2 PRL/1,000 PRL cells for flight and
ground samples, respectively, P < 0.05; ventral: 406 +_
72 and 375 _+ 24 ng NB-2 PRL/1,000 PRL cells for flight
and ground samples, respectively, not significant). By
the mitogen assay, PRL release from the dorsal and
ventral cells in microgravity showed the most diverse
response (dorsal: 69 _+ 25 and 199 _+ 32 ng m-PRL/1,000
PRL cells for flight and ground samples, respectively,
P < 0.01); ventral: 249 _+ 27 and 130 _+ 10 ng m-PRL/
1,000 PRL cells for flight and ground samples, respec-
tively, P < 0.01).
DISCUSSION
Because PRL bears a close structural similarity to
GH, studies that are focused on one hormone often
involve the other. In this way, comparisons of data
involving the two hormones often help delineate the
specificity of the hormonal effect. Studies that identify
common features between GH and PRL are often those
involving either intracellular processing or release of
these hormones. Because the physiological responses
resulting from the actions of either GH or PRL on the
target cells are usually different, a major focus of this
study was a determination of the effects of spaceflight
on the activity of PRL molecules.
Observations appearing in the literature -30-40
years ago implicated pituitary PRL in the control of
immune tissue (1). Only in the last 10 yr has that role
been better defined. For example, 1 ) PRL appears to be
an activator of T-cell function (21) and 2) PRL binds to
well-characterized receptors on the surfaces of certain
T cells, B cells, and macrophages (18). Because some of
these same immune cell activities are compromised
during and after spaceflight (3, 4, 11, 16), a purpose of
the 1992 pituitary cell culture flight experiment (in
addition to studying GH cells) (8) was to find out
whether microgravity-induced changes also happened
in PRL cell structure and function.
It has been recognized for many years that PRL and
GH are separate molecules that are produced, stored,
976 PROLACTIN AND SPACEFLIGHT
Extracellular Intracellular
Fig. 6. Release and content ofbioactive (mitogen
assay) PRL from mixed, band 1, and band 2 cells
without hydrocortisone during and after micro-
gravity. Data are means _+SE expressed relative
to number of PRL cells seeded into vials; n = 3
vials. Error bars not shown fit within symbol.
*P < 0.05. ***P < 0.001.
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and released from separate cell types in the anterior
pituitary. More recently, we have come to realize that
PRL exists both within the gland and the bloodstream
in a variety of different molecular forms, e.g., oligo-
meric, proteolytically cleaved, deamidated, phosphory-
lated, and glycosylated (20). The data obtained by
gel-exclusion HPLC (Fig. 8) show that microgravity
does not significantly change the apparent molecular
weights of secreted PRL; therefore, it seems unlikely
that aggregation or proteolytic cleavage of PRL is
occurring as a result of spaceflight. On the other hand,
the addition of HC to the culture medium tends to lower
monomeric PRL during spaceflight. The reason(s) why
HC negatively affects the release of low-molecular-
weight PRL from band 2 ground control cells is un-
known.
In addition to molecular heterogeneity, the evidence
for cellular heterogeneity in the PRL cell population is
unequivocal. Not only are there PRL cell subpopula-
tions within the gland [based on data indicating differ-
ences in PRL cell size, density, and laser light scatter (9,
15)], but newer observations describing a cell type that
coreleases both PRL and GH (the mammosomatotroph)
are now frequent. What is known about the morphology
of the PRL cell after spaceflight?
Thapar et al. (23) recently evaluated PRL cell mor-
phology of male rats after a 7-day spaceflight using
techniques of histology, immunohistochemistry, mor-
phometry, electron microscopy, and in situ hybridiza-
tion. In their thorough study, they reported that 1) PRL
cells appeared "evenly distributed throughout the gland,
although there were some foci in which their accumula-
tion was especially dense"; 2) PRL cells showed typical
ultrastructure; 3) PRL cells had nuclear-to-cytoplasmic
ratios that were unaffected by flight; and, finally, 4)
PRL cells had signal intensities of PRL mRNA that
were comparable in both groups. In addition to the cell
culture study reported here, our laboratory also did
morphological analyses on pituitary PRL cells from
spaceflown male rats [3 flights (7)]. We failed to find
differences in the number, size, staining intensity, and
cytoplasmic area hormone occupancy between ground
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and flight PRL cells. Therefore, the collective data of
Thapar et al. (23) and our group (7) permit the inescap-
able conclusion that PRL cell morphology is not affected
by short-term spaceflight.
How, then, can the functional differences in PRL cells
that we previously reported from spaceflown rats (7),
coupled with the numerous differences found in the
present flight experiment (Figs. 2-8), be reconciled
with these negative morphological data? We believe
that posttranslational modifications of hormone mol-
ecules before their release could account, in part, for
the apparent discrepancy. Such modifications are known
to occur in PRL cells. For example, the recent studies of
Walker (25) and Wang and Walker (26) show that PRL
isoforms, molecules with the same molecular weight
but different net charge, differ in their extent of phos-
phorylation. Most recently, this group showed that
nonphosphorylated PRL promotes NB-2 cell prolifera-
tion, whereas the phosphorylated form inhibits this
response. One-tenth the concentration of phosphory-
lated PRL neutralized the NB-2 cell growth-promoting
effects of the rest of the PRL present. Other data from
this same group demonstrate that the physiological
status of the animal (e.g., different stages of the estrous
cycle) reproducibly changes the ratio of phosphorylated
to nonphosphorylated PRL molecules released from the
pituitary (6).
A summary chart of the flight data from this cell
culture experiment compared with ground control
samples clearly shows that all flight media and intracel-
lular extracts contain significantly less iPRL (Fig. 9).
On the other hand, the results obtained from the two
bioassays are often contradictory in that they do not
agree between themselves and sometimes the PRL
activity from flight group samples is even greater than
from the ground samples. It is not difficult to imagine
physiological situations in which the degree ofphosphor-
ylation of the PRL molecule might affect its bioactivity
on lymphocytes differently because the lymphocytes we
used were from either a tumor cell line or primary
splenocytes. It would not be surprising that recognition
of microgravity-induced phosphorylated PRL might be
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recognized differently in the two assays. In support of
this argument, we refer to two recent studies from our
laboratory (12, 13) that show that reciprocal activities
between these two assays correlate with the physiologi-
cal state of the animal. Thus PRL released 1 ) from cells
contained in different regions of the pituitary glands of
female rats that are in different stages of the estrous
cycle (13) and 2) from cells of rats bearing carcinogen-
induced mammary tumors (12) both show differential
activities in the two bioassays. It is relevant to point out
that we were able to identify two different types of PRL
cells (based on their laser light scatter) in the glands of
donors at different stages of the estrous cycle; these
changed in frequency within the dorsal and ventral
regions of the gland at specific stages. We also found
that the ratios of PRL activities released from these
cells, measured by immunoassay and bioassay, also
correlated with cycle stage and region (13). In this
regard, it is especially interesting that our new data
also show that the region from which the PRL cells
were prepared make a difference both in terms of their
sensitivity to changes in gravity levels as well as in the
activity of PRL molecules released from them. Because
the only significant effect of flight on regional GH
release was from dorsal cells (8), it is clear that regional
changes in PRL cells reflect more sensitivity and plastic-
ity to their gravity environment. The reason(s) for
these differences is unknown; however, it offers in-
sights into experimental designs for future flights.
Complex biological mechanisms that assure proper
function of hormone-producing cells in a neuroendo-
crine system may be remarkably similar to those
controlling a properly functioning immune system. In
fact, common molecular mechanisms of communication
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Table 1. Effect of microgravity on release of iPRL forms based on size distribution patterns after fractionation
by gel exclusion HPLC
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Molecular
Weight
Range,
thousands
iPRL, ng
Without hydrocortisone With hydrocortisone
Ground Flight Ground Flight
Mixed 990-240 421 -- 78 166 _+30 182 -+8 503 +_62*
240-59 793 +- 130 148 -+23* 399 _+56 398 +-51
59-10 3,295 _+541 1,254 _+456 4,927 -+1,257 1,000 _+162"
E 4,509 1,569 5,508 1,901
Band 1 990-240 326 _+174 317 +_182 246 _+126 167 -- 38
240-59 612 -+297 218 -+73 242 _+53 128 _+30
59-10 3,092 -+524 1,708 +-251 3,749 _+753 1,298 -+18"
E 4,030 2,243 4,237 1,593
Band 2 990-240 44 _+5 85 -+27 36 _+24 43 _+4
240-59 69 +_20 122 _+30 39 ± 18 42 _+13
59-10 1,957 -+360 771 +-77* 840 +_42 674 -+149
2,070 978 915 759
Values are immunoreactive prolactin (iPRL) in combined high-performance liquid chromatography (HPLC) fractions -+ SE; n = 3 cell
groups. *P -< 0.05 compared with ground cells.
between these two systems via shared signal molecules
(including peptide hormones, peptide neurotransmit-
ters, and cytokines) have been identified by Blalock and
Weigent (2) as the means by which the integration of
organ system function is realized; in fact, these ideas
"could change our understanding of physiology and
thus influence medical practice." Common molecular
mechanisms of communication must certainly take
place as cells sense and respond to changes in their
environments. Because cells accomplish their communi-
cations in a fluid environment and because the behav-
ior of fluids is very different in microgravity, it is
perhaps not too surprising that pituitary cell physiol-
ogy is affected by spaceflight. Our experimental data
establish that hormone-producing pituitary cells sense
gravity and respond by changing the amounts and
activities of product that are contained in, and released
from, the cell. At this point, we do not understand the
biochemical mechanism(s) by which these changes take
place, but our data establish that they can be manipu-
lated by changing the cell culture system. An under-
standing of the equally complex but poorly understood
biophysical mechanisms involved in the cellular adapta-
tion to microgravity will also be required to establish
countermeasures to physiological changes encountered
during manned spaceflight. Our studies, together with
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EIA
RELEASED PRL INTRACELLULAR PRL
(No Hydrocortisone) (No Hydrocortisone)
j Postflight Postflight
Culture Culture
Cell 3 days 6 days Assay Cell 6 days
Mixed __ Nb-2 Mixed
Band 1 Band 1
Band 2 Band 2
Mixed --_ Mitogen Mixed
Band 1 Band 1
Band 2 _ 'Band 2
Mixed _ EIA Mixed
Band 1 Band 1
Band 2
RELEASED PRL INTRACELLULAR PRL
(With Hydrocortisone)
Nb-2
Band 2
Mitogen Mixed
V_////J//////_/ Band 1 v_//'////////._
Mitogen
Fig. 9. Summary of flight effects on
extracellular and intracellular PRL as
a function of cell sample, hormone as-
say, hydrocortisone, and postflight incu-
bation. EIA, enzyme immunoassay. Re-
sponses between flight and ground are
represented as not significant (open
boxes); flight significantly greater than
ground (P < 0.05; hatched boxes); flight
significantly less than ground (P <
0.05; solid boxes).
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a growing number of others, thus serve as a precursor
to follow on investigations that can be done on a routine
basis when the new Space Station is operational.
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